GB202205161D0 - Nucleotide delivery of cancer therapy - Google Patents

Nucleotide delivery of cancer therapy

Info

Publication number
GB202205161D0
GB202205161D0 GBGB2205161.9A GB202205161A GB202205161D0 GB 202205161 D0 GB202205161 D0 GB 202205161D0 GB 202205161 A GB202205161 A GB 202205161A GB 202205161 D0 GB202205161 D0 GB 202205161D0
Authority
GB
United Kingdom
Prior art keywords
cancer therapy
nucleotide delivery
nucleotide
delivery
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2205161.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IO Biotech ApS
Original Assignee
IO Biotech ApS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IO Biotech ApS filed Critical IO Biotech ApS
Priority to GBGB2205161.9A priority Critical patent/GB202205161D0/en
Publication of GB202205161D0 publication Critical patent/GB202205161D0/en
Priority to PCT/EP2023/054573 priority patent/WO2023161350A1/en
Ceased legal-status Critical Current

Links

GBGB2205161.9A 2022-02-24 2022-04-08 Nucleotide delivery of cancer therapy Ceased GB202205161D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2205161.9A GB202205161D0 (en) 2022-04-08 2022-04-08 Nucleotide delivery of cancer therapy
PCT/EP2023/054573 WO2023161350A1 (en) 2022-02-24 2023-02-23 Nucleotide delivery of cancer therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2205161.9A GB202205161D0 (en) 2022-04-08 2022-04-08 Nucleotide delivery of cancer therapy

Publications (1)

Publication Number Publication Date
GB202205161D0 true GB202205161D0 (en) 2022-05-25

Family

ID=81653152

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2205161.9A Ceased GB202205161D0 (en) 2022-02-24 2022-04-08 Nucleotide delivery of cancer therapy

Country Status (1)

Country Link
GB (1) GB202205161D0 (en)

Similar Documents

Publication Publication Date Title
EP4010081A4 (en) Combination therapy for treatment of cancer
GB202114972D0 (en) Gene therapy
IL307964A (en) Combination therapy for cancer treatment
GB202205161D0 (en) Nucleotide delivery of cancer therapy
GB202003618D0 (en) Gene Therapy
EP4087563A4 (en) Combination cancer therapy using chk inhibitor
GB202002202D0 (en) Gene therapy
GB202215198D0 (en) Gene therapy treatment
GB202318158D0 (en) Cancer therapy
GB202302018D0 (en) Cancer therapy
GB202218395D0 (en) Cancer therapy
GB202212918D0 (en) Cancer therapy
GB202316264D0 (en) Gene therapy
GB202315668D0 (en) Gene therapy
GB202214445D0 (en) Gene therapy
GB202212092D0 (en) Gene therapy
GB202206346D0 (en) Gene therapy
AU2023901713A0 (en) Targeted dual administration cancer therapy
EP4083213A4 (en) Cancer gene therapy drug
GB202311976D0 (en) Treatment of cancer
GB202218181D0 (en) Treatment of cancer
GB202300865D0 (en) Delivery of oligonucleotides
GB202005321D0 (en) Gene therapy treatment
AU2022903962A0 (en) Targeted combination cancer therapy
IL304436A (en) Cancer therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)